Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationBone MarrowTransplantation, AutologousHematopoietic Stem Cell MobilizationBone Marrow CellsTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisHematopoietic Stem CellsStem CellsGraft vs Host DiseaseBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsGraft SurvivalMelphalanCyclophosphamideCombined Modality TherapyTissue DonorsBone and BonesBusulfanBone Marrow DiseasesMultiple MyelomaStem Cell TransplantationHematopoiesisBlood CellsWhole-Body IrradiationTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsBone Marrow PurgingBlood Cell CountLeukemiaCord Blood Stem Cell TransplantationLymphoma, Non-HodgkinTransplantation ChimeraRecurrenceAnemia, AplasticHistocompatibilityHistocompatibility TestingEtoposideMyeloablative AgonistsImmunosuppressive AgentsRemission InductionTime FactorsThiotepaColony-Forming Units AssayAntineoplastic Agents, AlkylatingCell DifferentiationFlow CytometryLeukemia, Myeloid, AcuteCytomegalovirus InfectionsRetrospective StudiesTransplantation, IsogeneicBone Marrow ExaminationCell SeparationPlatelet CountDisease-Free SurvivalCells, CulturedLeukocyte CountInfectionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunophenotypingBlood DonorsBone Marrow NeoplasmsSurvival AnalysisSurvival RateCytarabineRecombinant ProteinsT-LymphocytesIfosfamideHodgkin DiseaseMyelodysplastic SyndromesLymphocyte DepletionHematologic DiseasesEmbryonic Stem CellsLeukocytes, MononuclearCyclosporineAntigens, CDSalvage TherapyLymphomaImmunosuppressionAdult Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaMice, Inbred C57BLVidarabineGranulocytesVincristineOpportunistic InfectionsBone RemodelingAcute DiseaseStem Cell FactorNeoplasmsImmunomagnetic SeparationPOEMS SyndromeLeukocyte TransfusionBlood Group IncompatibilityNuclear Family